Randomized trial demonstrates that monthly cash transfers slow epigenetic aging in young low-income children, suggesting financial aid may biologically buffer early development.
Here we present epigenetic findings from a randomized controlled trial studying the impact of unconditional cash gifts of US$333 per month (children n = 313; mothers n = 329) or US$20 per month (children n = 423; mothers n = 448) to US mothers with low income during their child's first four years of life. Salivary DunedinPACE-pace of aging, a DNA-methylation predictor of healthy lifespan, and Epigenetic-g, a DNA-methylation biomarker of cognition, were preregistered as secondary outcomes (clinical trial identifier NCT03593356 ). As hypothesized, high-cash compared with low-cash gifts caused a -0.17 s.d. (95% confidence interval -0.32 to -0.01, P = 0.037) difference in children's DunedinPACE. We found no evidence supporting our hypothesis that higher cash gifts increased children's Epigenetic-g, although it did correlate with children's brain activity. There was no evidence that the cash gift had an impact on these epigenetic indices in mothers. These findings show a detectable impact of monthly unconditional cash received through early childhood on epigenetic indices of 4-year-old children in families with low income. Whether this epigenetic effect persists and how it may relate to behavioural and health outcomes remains unknown.
No takes yet. Share an insight, caveat, or question.
Raffington et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: